An interventional study of Implementation Facilitation in Alcohol-Related Disorders and Psychiatric Disorder, sponsored by University of Maryland, Baltimore. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by University of Maryland, Baltimore · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 107 studies in Alcohol-Related Disorders with a site in United States — 13 open to participants now, 18 under way, 1 of them phase 3. Alcohol-Related Disorders · United States.
Among the 107 studies in Alcohol-Related Disorders with a site in United States, this one is the 64th largest by planned enrollment of the 94 interventional ones that give a count, is one of 6 that started in 2025, is one of 48 with no phase, reaches primary completion later than 7 of the 17 other live ones, and was the 105th registered.
156 studies on the registry are indexed under Alcohol-Related Disorders; 23 are open to participants now.
Browse Alcohol-Related Disorders studies →13 of the 107 studies in Alcohol-Related Disorders with a site in United States are open now. Recruiting first, the newest first:
University of Pittsburgh · Sites in United States
Ages 14–18 · Healthy volunteers
University of Virginia · Sites in United States
Ages 18–44 · Women only · Healthy volunteers
VA Office of Research and Development · Sites in United States
Ages 18+
Yale University · Sites in United States
Ages 21–65
Emory University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 16 Alcohol-Related Disorders studies recruiting now, 5 (31%) set no upper age limit and 7 (44%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
107 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 16 · Phase 2 25 · Phase 3 5 · Phase 4 5
First in 1994; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 101 across 131 interventional studies indexed under Alcohol-Related Disorders.
Median enrollment 86 across the 94 interventional studies, 300 across the 13 observational. Of the 80 that completed or were terminated, 37 (46%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 107 have an industry lead sponsor. The 10 most frequent:
University of Maryland, Baltimore is the lead sponsor of 700 studies on the registry; 131 are open to participants now.
Of its 92 completed or terminated interventional studies of FDA-regulated products, 66 (72%) have results posted.
University of Maryland, Baltimore has 3 studies filed under Alcohol-Related Disorders — fewer than ten, so there is no comparison to draw.
7 of the studies in Alcohol-Related Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05807139National Institute on Drug Abuse (NIDA)Spironolactone in Alcohol Use Disorder (SAUD) | 2026-12-31 |
| NCT04391816National Institute on Alcohol Abuse and Alcoholism (NIAAA)COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study | 2026-12-31 |
| NCT05910580Emory UniversityImproving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years | 2027-05-31 |
| NCT07053098University of Maryland, BaltimoreExternal Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting | 2027-05-31 |
| NCT06444295University of WashingtonTesting the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault | 2027-07-15 |
Add all 7 to your calendar (.ics) → With an account.
Among the 107 studies in Alcohol-Related Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.
This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics. Guided by the integrated Promoting Action on Research Implementation in Health Services framework, an external facilitator will work with each clinics' internal champion to (1) provide clinic level education on MAUD in non-specialty care settings, (2) provide clinic level training in using a standardized screen measure for alcohol use disorder, documenting screening results in the electronic health record, and documenting alcohol use disorder diagnosis in the electronic health record, (3) help internal champions use an audit and feedback system for weekly review of MAUD education and prescribing, (4) help internal champions do weekly care coordination for patients with major mental illness and alcohol use disorder, and (5) make educational materials on MAUD available on site to patients so they are informed about these treatment options. Internal champions and clinics will have access to consultation from a MAUD clinician expert. These activities will take place across pre-implementation and implementation phases and will be followed by a post-implementation facilitation sustainment period during which clinics and champions continue implementation on their own. Formative Evaluation activities will take place throughout; at the end of the sustainment phase, MAUD outcomes will be assessed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This Implementation Facilitation Intervention will include external facilitation, staff training, patient education, audit and feedback, and care coordination.
Other: Implementation Facilitation
Implementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.
Prescribing medications for alcohol use disorder
Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic
Time frame: 6 months after the end of implementation facilitation
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2025 (actual). Primary completion is estimated for May 2027, 26 months after the start.
Of 49 non-industry interventional studies with no phase under Alcohol-Related Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 44. This study's planned 26 months is below that.
Counting every sponsor, half of 49 studies reached it within 30 months; a quarter within 17 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Maryland, Baltimore →